Operating

Change in AR

Over 3 years (FY 2021 to FY 2025), Change in AR shows an upward trend with a -100.0% CAGR. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementCash Flow Statement
SectionOperating
CategoryLiquidity
SignalLower is better
VolatilityModerate
First reportedQ1 2019
Last reportedQ4 2025Feb 25, 2026

How to read this metric

A decrease is generally positive as it indicates faster collection of cash from customers.

Detailed definition

This measures the change in the amount of money owed to the company by customers for goods or services delivered on cred...

Peer comparison

Standard metric for all companies; peers in medical devices monitor this closely to manage working capital cycles.

Metric ID: change_in_accounts_receivable

Historical Data

18 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25
Value-$1.04M$885.00K-$1.48M-$546.00K$241.00K-$684.00K-$267.00K-$678.00K-$1.49M-$2.20M-$1.25M$0.00$0.00$0.00$0.00$0.00$0.00-$0.00
QoQ Change+185.3%-267.6%+63.2%+144.1%-383.8%+61.0%-153.9%-119.0%-48.2%+43.0%+100.0%
YoY Change+123.2%-177.3%+82.0%-24.2%-716.2%-221.8%-85.0%+100.0%+100.0%+100.0%
Range-$2.20M$885.00K
CAGR-100.0%
Avg YoY Growth-71.9%
Median YoY Growth+28.9%

Frequently Asked Questions

What is Revolution Medicines, Inc.'s change in ar?
Revolution Medicines, Inc. (RVMD) reported change in ar of -$0.00 in Q4 2025.
What is the long-term trend for Revolution Medicines, Inc.'s change in ar?
Over 3 years (2021 to 2025), Revolution Medicines, Inc.'s change in ar has grown at a -100.0% compound annual growth rate (CAGR), from -$464.00K to $0.00.
What does change in ar mean?
The change in money owed to the company by customers for past sales.